BUPIVACAINE HYDROCHLORIDE INJECTION, USP
BAXTER CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BUPIVACAINE HYDROCHLORIDE INJECTION, USP in Canada?
Not currently. The most recent shortage report for BUPIVACAINE HYDROCHLORIDE INJECTION, USP 7.5MG is marked resolved (last updated August 12, 2024).
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02488930
Strength
7.5MG
Dosage Form
SOLUTION
Route
RETROBULBAR EPIDURAL
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Tier
Unrated
Last Updated
2024-08-12
Reason for Shortage
Requirements related to complying with good manufacturing practices.
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160